Patient preference for dissection of sentinel nodes outside level I-II of the axilla

Acta Oncologica

Volumn 41, Issue 7-8, 2002, Pages 652-658

  Leidenius, Marjut H ^a   Von Smitten, Karl A ^a   Hietanen, Päivi S ^b  

^a Maria Hospital   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; PATIENT TREATMENT; SURVEYS; TUMORS;

SENTINEL NODES;

ONCOLOGY;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; QUESTIONNAIRE; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; SURGICAL TECHNIQUE;

EID: 0036964711     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418602321028274     Document Type: Article

References (19)

1. Morrow M, Foster RS. Staging of breast cancer. A new rationale for internal mammary node biopsy. Arch Surg 1981; 166: 748-51.
2. Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 1985; 202: 702-7.
3. Noguchi M, Ohta N, Kioyasaki N, Taniya T, Miyazaki I, Mizukami Y. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Cancer 1991; 68: 1918-25.
4. Arriagada R, Guinebretiere J-M, Le ME. Do internal mammary chain nodes matter in the prognosis of axillary node-negative breast cancer? Acta Oncol 2000; 39: 307-8.
5. Arriagada R, Le ME. Adjuvant radiotherapy in breast cancer. The treatment of lymph node areas. Acta Oncol 2000; 39: 295-305.
6. Freedman GM, Fowble BL, Nicolau N, et al. Should internal mammary lymph nodes in breast cancer be a target for the radiation oncologist? Int J Radiat Oncol Biol Phys 2000; 46: 805-14.
7. O'Hea BJ, Hill ADK, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998; 186: 423-7.
8. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 1998; 339: 941-6.
9. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-83.
10. Haigh PI, Hansen NM, Giuliano AE, Edwards K, Ye W, Glass EC. Factors affecting sentinel node localization during preoperative breast lymphoscintigraphy. J Nucl Med 2000; 41: 1682-8.
11. Jansen L, Doting MHE, Rutgers EJTh, de Vries J, Valdés Olmos RA, Nieweg OE. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg 2000; 87: 920-5.
12. Uren RF, Howman-Giles R, Renwick SB, Gillet D. Lymphatic mapping of the breast cancer: locating the sentinel lymph nodes. World J Surg 2001; 25: 789-93.
13. van der Ent FWC, Kengen RAM, van der Pol HAG, Povel JACM, Stroeken HJG, Hoofwijk AGM. Halstedt revisited: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg 2001; 234: 79-84.
14. Valdés Olmos RA, Tanis PJ, Hoefnagel CA, et al. Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun 2001; 22: 579-86.
15. Galper SR, Lee SJ, Tao ML, et al. Patient preference for axillary dissection in the management of early-stage breast cancer. J Natl Cancer Inst 2000; 92: 1681-7.
16. Fleissig A, Jenkins V, Fallowfield L. Results of an intervention study to improve communication about randomised clinical trials of cancer therapy. Eur J Cancer 2001; 37: 322-31.
17. Hietanen P, Aro AR, Holli K, Absetz P. Information and communication in the context of a clinical trial. Eur J Cancer 2000; 36: 2096-104.
18. Daugherty CK. Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. J Clin Oncol 1999; 17: 1601-17.
19. Hayman JA, Fairclough DL, Harris JR, Weeks JC. Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer. J Clin Oncol 1997; 15: 1252-60.